Continuous caudal anesthesia for inguinal hernia repair in former preterm infants

J Clin Anesth. 1993 Mar-Apr;5(2):129-33. doi: 10.1016/0952-8180(93)90140-a.

Abstract

Study objective: To determine the feasibility of continuous caudal anesthesia with 2-chloroprocaine in conscious former preterm infants undergoing inguinal hernia repair.

Design: Prospective study.

Setting: University-affiliated children's hospital.

Patients: Ten former preterm infants, ASA physical status II and III, who were 35 to 49.5 weeks postconceptional age at the time of surgery.

Interventions: Caudal anesthesia was administered via an indwelling catheter using a loading dose of 1 ml/kg (30 mg/kg) of 3% 2-chloroprocaine, followed by incremental doses of 0.3 ml/kg (9 mg/kg) to achieve a level of T4 to T2. The block was maintained by a minimum infusion rate of 30 mg/kg/hr (1 ml/kg/hr) of the same local anesthetic solution.

Measurements and main results: The mean cumulative dose of 2-chloroprocaine was 2.8 +/- 1.0 ml/kg/hr (84 +/- 30 mg/kg/hr) infused over a mean duration of 95 +/- 35 minutes. Serum cholinesterase concentration and plasma 2-chloroprocaine concentration were measured in five infants.

Conclusions: Three percent 2-chloroprocaine can be used effectively for continuous caudal anesthesia in conscious, former preterm infants for inguinal hernia and penoscrotal surgical procedures lasting 85 to 170 minutes.

MeSH terms

  • Anesthesia, Caudal*
  • Anesthetics, Local* / administration & dosage
  • Anesthetics, Local* / blood
  • Anesthetics, Local* / pharmacology
  • Blood Pressure / drug effects
  • Cholinesterases / blood
  • Gestational Age
  • Heart Rate / drug effects
  • Hernia, Inguinal / surgery*
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature*
  • Procaine / administration & dosage
  • Procaine / analogs & derivatives*
  • Procaine / blood
  • Procaine / pharmacology
  • Prospective Studies

Substances

  • Anesthetics, Local
  • Procaine
  • chloroprocaine
  • Cholinesterases